Overview
Lobbying Costs
50,000€ - 99,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.5 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Organon & Co (Organon)
EU Transparency Register
174451245812-18 First registered on 15 Mar 2022
Goals / Remit
Organon is a biopharmaceutical company. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. And we bring these important therapies around the world, with an international footprint that serves people in more than 140 markets.
Main EU files targeted
Women Health
Sexual Health and rights
Family Planning
Fertility
Biosimilar pharmaceutical products
Joint Procurement
Pharmaceutical Products pricing
Environment protection
Pharmaceutical legislation
GDPR
MDR
REACHAddress
Head Office
30 Hudson Street
New Jersey NJ 07302
UNITED STATESEU Office
Rue du commerce 31 (WeWork building)
Brussels
BELGIUMWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 50% 1 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
one FTE covering EU affairs and support for over 30 markets in Europe (incl. non - EU) and in Canada
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
EUCOPE: https://www.eucope.org/
Biopharmaceutical Industry Organization: https://www.bio.org/
OECD EMNET: https://www.oecd.org/dev/emnet-emerging-markets-network.htm
American Central Europe Business Association: https://aceba.org/
Pharmaceutical Aerosol Consortium: https://www.ipacrs.org/
US - Asean Business Council: https://www.usasean.org/
US - China Business Council: https://www.uschina.org/
Latin American Federation of the Pharmaceutical Industry: https://fifarma.org/en/about/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
50,000€ - 99,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount acumen public affairs 25,000€ - 49,999€ acumen public affairs 25,000€ - 49,999€ acumen public affairs 50,000€ - 99,999€ Intermediaries for current year
Name acumen public affairs Closed year Costs
50,000€ - 99,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Round table discussions on women health and well - being in Europe
Collaboration with European Parliamentary Forum for Sexual Health and Rights on Contraception Atlas and sexual health education
Collaboration with Vlerick Business School on economical aspects of investing in women health
Collaboration with Fertility Europe on Fertility emotional journey and access to treatment
Collaboration with European Institute for Women's Health on overall EU women health strategyOther activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 29 Jan 2025 Location Brussels Subject EU-US trade Cabinet Cabinet of Commissioner Maroš Šefčovič Attending - Adam Romanowski (Cabinet member)
- Chiara Galiffa (Cabinet member)
- Bernd Biervert (Cabinet member)
- Renáta Goldírová (Cabinet member)
Other Lobbyists - Intuitive Surgical, Inc
- MSD (Europe), Inc. (Merck Sharp & Dohme)
- Motorola Solutions Incorporated
- Boeing International Corporation - Belgium Branch Office
- Excelerate Energy
- Magna Services of America, Inc.
- Stryker
- Marriott International
- Pharmaceutical Research and Manufacturers of America
- Abbott
- ExxonMobil Petroleum & Chemical
- JPMorgan Chase & Co.
- The Cigna Group
- Becton Dickinson
-
Date 29 Jan 2025 Location Brussels Subject Transatlantic trade relations in the second Trump administration. DG Trade Attending - Sabine Weyand (Director-General)
- Peter Matthias Jorgensen (Head of Unit)
Other Lobbyists - Pharmaceutical Research and Manufacturers of America
- ExxonMobil Petroleum & Chemical
- Excelerate Energy
- Motorola Solutions Incorporated
- The Cigna Group
- Marriott International
- Magna Services of America, Inc.
- Boeing International Corporation - Belgium Branch Office
- GE Vernova
- MSD (Europe), Inc. (Merck Sharp & Dohme)
- JPMorgan Chase & Co.
- Becton Dickinson
- Abbott
- Stryker
- Intuitive Surgical, Inc
-
Date 27 Jan 2025 Location Brussels Subject Policies to improve EU’s business environment and competitiveness, business concerns related to regulatory burdens, and key sectoral challenges. Cabinet Cabinet of Executive Vice-President Stéphane Séjourné Attending - Ioan-Dragos Tudorache (Cabinet member)
Other Lobbyists - JPMorgan Chase & Co.
- The Chemours Company
- Excelerate Energy
- Chamber of Commerce of the United States of America
- Motorola Solutions Incorporated
- Pharmaceutical Research and Manufacturers of America
- W. L. Gore & Associates GmbH
- The Cigna Group
- Intuitive Surgical, Inc
- Marriott International
- Becton Dickinson
- MSD (Europe), Inc. (Merck Sharp & Dohme)
- Abbott